Tsveta Milanova, Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 5,608 shares at $32.18 ($180K) on 2025-01-06, disclosed to the SEC on 2025-01-07.
Scheduled sale ($180k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.18 | 2,804 | $90K | 50.0% |
| 2 | $32.18 | 2,804 | $90K | 50.0% |
| Total | $32.18 avg | 5,608 | $180K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-07 | $78K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $186K | — | Filing → |